Diazyme Inks US Distribution Deal for Maccura Biotechnology Coronavirus Test

Jul 31, 2020

|

NEW YORK — Diazyme Laboratories said on Thursday that it signed an agreement to market and distribute Maccura Biotechnology's SARS-CoV-2 molecular diagnostic in the US.

Specific terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Even Bigger

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Got Into the Lab Machines

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Not Going to Pay

Science reports that a Dutch research funding agency is combating a ransomware attack.

Science Papers Present Haplotype-Resolved Genomes, MiRNA-Linked Complex Tied to Ribosomal Protein Production

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.

Featured White Papers

Congenica Enables Five Minute Diagnosis of Previously Unsolved Case

Congenica CNV Calling for Exomes Whitepaper

Congenica Splice Site Finder White Paper

Expediting an Accurate Diagnosis through Streamlined Clinical Workflows

Mar

11

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

16

Featured Webinar

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Wastewater based epidemiology (WBE) has been established as a viable, valuable, and cost-effective means to monitor infectious disease within a community.

Mar

17

Featured Webinar

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Mar

18

Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Viruses mutate as they strive to thrive in response to selective pressures.

Menu

Diazyme Inks US Distribution Deal for Maccura Biotechnology Coronavirus Test

To read the full story....

Breaking News

People in the News: New Appointments at Qiagen, ImmunoScape, 908 Devices, More

New Products Posted to GenomeWeb: Twist Bioscience, New England Biolabs, Promega, More

In Brief This Week: Thermo Fisher Scientific, Fourth Circuit Court of Appeals, Invitae, and More

GenDx HLA Genotyping Products Receives Health Canada IVD Approval

Personalis Q4 Revenues up 11 Percent

Natera Revenues Grow 35 Percent in Q4

The Scan

Even Bigger

Got Into the Lab Machines

Not Going to Pay

Science Papers Present Haplotype-Resolved Genomes, MiRNA-Linked Complex Tied to Ribosomal Protein Production

Featured White Papers

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

The Predictive Power of Poop: COVID-19 Wastewater Surveillance to Inform Public Health Decisions in Colorado

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

What's Popular?

Novacyt Obtains CE Mark for Extraction-Free COVID-19 PCR Test

ACMG Lobbying State Legislatures on Genetic Counselors' Scope of Practice Draws Criticism

Luminex Shares Surge on Rumor of Acquisition by DiaSorin

Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year

Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch

Sponsorships